766P Prognostic effect of systemic immune-inflammation index (SII) in 987 patients with advanced/metastatic urinary tract carcinoma (mUTC) treated with atezolizumab in the real-world global SAUL study
| Autor: | Mego, M., Huddart, R.A., Voortman, J., Ong, M., Gedye, C., Gurney, H., Fay, A.P., Bamias, A., Mellado Gonzalez, B., Loriot, Y., Merseburger, A.S., Castellano Gauna, D., de Ducla, S., Pavlova, J., Fear, S., Sternberg, C.N. |
|---|---|
| Zdroj: | In Annals of Oncology September 2020 31 Supplement 4:S591-S591 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|